Nobivac® Respira Bb
The UK’s first and only injectable Bordetella bronchiseptica vaccine, from MSD Animal Health.
Introducing Nobivac® Respira Bb
Expand your offering of canine respiratory vaccines with our new injectable solution. A convenient complement to Nobivac® KC, Nobivac® Respira Bb provides protection against Bordetella bronchiseptica when intranasal vaccination is not possible or appropriate, increasing the number of dogs that can be successfully vaccinated.
Nobivac® Respira Bb Product Information
Containing a unique fimbrial antigen subunit of Bordetella bronchiseptica, Nobivac® Respira Bb reduces clinical signs of upper respiratory tract disease and bacterial shedding post infection1. Nobivac Respira Bb is available now in a 10 dose multi-dose vial for subcutaneous injection.
For full product information including presentation and active ingredients, click the link below.
Canine Infectious Respiratory Disease
Canine infectious respiratory disease (CIRD) is a widespread syndrome, being one of the most globally prevalent infectious diseases of dogs2,3. Bordetella bronchiseptica plays an important role in this disease complex. Clinical signs of CIRD can last from days to weeks which can prove debilitating for the pet, and distressing for dog owners to witness.
Nobivac® Respira Bb is an inactivated subunit vaccine containing the fimbrial antigen of Bordetella bronchiscepta. POM-V
Further information is available from the SPC, Datasheet or package leaflet.
MSD Animal Health UK Limited. Registered office Walton Manor, Walton, Milton Keynes MK7 7AJ, UK. Registered in England & Wales no. 946942.
Advice should be sought from the medicine prescriber.
Use Medicines Responsibly.
1. Nobivac Respira Bb. Summary Of Product Characteristics
2. Buonavoglia C, Martella V (2007) Canine respiratory virus. Veterinary Research, 38, 355-373.
3. Schulz BS, Kurz S, Weber K, Balzer HJ, Hartmann K (2014) Detection of respiratory viruses and Bordetella bronchiseptica in dogs with acute respiratory tract infections. Veterinary Journal, 201, 365-369.